Physician

Prasanna Sugathan, M.D.

According to 2025 Medicare claims, Prasanna Sugathan, M.D. (NPI: 1598847733) practices cardiology in the Lake Charles, LA market, with the plurality of this provider's patient population coming from Calcasieu, LA. This provider's primary affiliated billing organization is IMPERIAL HEALTH, LLP (NPI: 1053352401; TIN: 721005645) and primary practice location at 70601-5724. Sugathan is affiliated with the Keystone ACO (ACO ID: A1552) and Aledade 35 Lagniappe MSSP Enhanced (ACO ID: A3899), participating under the MSSP model.

Sugathan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,594 traditional Medicare patients, billed 5,537 HCPCS/CPT codes, and received $335,651 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,897 prescription claims across 213 beneficiaries totaling $201,736 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 89 claims. Open Payments data shows 19 records totaling $571. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $120,197 and ending at $335,651. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $58,725 and ending at $201,736. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $13,628 to $846.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	909	2,331	$120,197
2016	1,012	2,387	$140,057
2017	285	508	$27,636
2018	951	1,789	$95,095
2019	829	1,557	$88,479
2020	762	1,297	$70,094
2021	120	198	$11,022
2022	688	2,055	$191,229
2023	1,164	3,103	$245,623
2024	1,594	5,537	$335,651

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	340	1,926	$58,725
2016	311	2,857	$60,315
2017	188	1,021	$15,016
2018	119	641	$25,807
2019	140	760	$39,750
2020	168	939	$62,237
2021	97	456	$33,315
2022	62	281	$21,056
2023	153	1,103	$111,144
2024	213	1,897	$201,736

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	95	142	$9,829
2016	85	241	$6,670
2017	22	89	$1,985
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	360	548	$85
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	326	337	$64
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	262	584	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	315	403	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	455	692	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	70	3,750	$72,063
Entresto	Sacubitril/Valsartan	71	2,897	$63,844
Jardiance	Empagliflozin	12	600	$12,256
Nexletol	Bempedoic Acid	22	900	$11,941
Xarelto	Rivaroxaban	14	540	$10,328

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$571	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Prasanna Sugathan, M.D.?

Tedicare shows public-source Medicare data for Prasanna Sugathan, M.D. (NPI 1598847733), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Prasanna Sugathan, M.D. have ACO affiliation data?

Prasanna Sugathan, M.D. is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552) and Aledade 35 Lagniappe MSSP Enhanced (MSSP, ACO ID A3899).

What billing organization is linked to Prasanna Sugathan, M.D.?

Prasanna Sugathan, M.D. is linked to IMPERIAL HEALTH, LLP (billing NPI 1053352401) in the available physician profile data.

Does Prasanna Sugathan, M.D. have Open Payments data?

Prasanna Sugathan, M.D. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.